Country: U.S.A.

Industry: Biotechnology

Year: 2021

Service(s): 17

Detailed: [CASE STUDY]

Paul Mola and Barry Merriman founded Roswell Biotechnologies in 2014. As veterans of genomic sequencing, they understood that precision medicine would fail to live up to its promise without a new technology to carry it over the threshold of its diagnostic limitations.

As Roswell Biotech, they created a computational architecture that not only incorporates the precision of biology through its direct application (no machine learning approximations and “AI” simulations), but one that also utilizes the immense potential of being easily scalable and applicable to existing software and digital technologies.

It’s a true microchip, but it’s also a gateway of discovery that leads into a new understanding of biology.

Just like Intel’s 4004 microchip brought us digitized information back in 1971, the Roswell ME Chip™ is the first to cross the frontier of digital biology, bringing us into a new age of biotechnology and revolutionizing health.

Roswell Biotechnologies developed a truly new technology with serious ramifications across major industries. But, it was difficult to comprehend.

Our job was to capture its technical prowess it in a completely unique visual narrative. We had to tell the story of the chip’s ingenuity in a way that reflects the reality of its technical specifications, while covering the vast expanse of its potential application.

The brand needed to embody the spirit of innovation behind their technology. However, it was crucial for Roswell to stand out as a company that delivers on the promises of progress — a claim too often casually tossed around in their industry.

The challenge was serious, and so were the founders of Roswell.

We seriously loved it.

During our initial discussions on scope and approach, the founders of Roswell immediately made themselves very clear: they wanted “the Rolls Royce of websites,” complete with a suite of premium visual assets and a full rebrand.

Our approach was centered around expressing Roswell’s credibility through a visual narrative that moves away from the tropes of tech startups; staying far away from vague statements, oversimplified or overcrowded charts, generic visuals, and text-heavy layouts bordering on technobabble.

We were determined to present their technology and values through a comprehensive, easy to follow, storyline that grips the audience with the gravity of Roswell’s technological achievement. This way, the user would be immersed into a visually eloquent storytelling experience — one that faithfully represents the reality of Roswell’s character, values, and technology. No oversimplification, and no information overload.

Roswell placed their trust in our ability and direction, and with our objectives set, we were ready to begin what turned out to be a fantastic project and a true partnership.

BRAND: Rebrand Roswell Biotech as the leading molecular electronics company that’s pioneering a new age of biotechnology, and transforming health. Express their character, accentuating the sophistication and impact of their technology, while retaining core legacy elements.

ASSETS: Create a full suite of new visual assets (static, animated, interactive, 3D, and 2D) that drive and/or support the visual and technical narrative. Focus on the technology, faithfully representing its technical elegance and functionality, while maintaining a clean aesthetic.

WEBSITE: Build a website around the story of Roswell’s technology and its implications for health and the biotech industry. Craft a balanced visual and educational experience through immersive storytelling. Assure it gradually covers all key aspects of the technology, highlighting the company’s values along the way.

We launched Roswell Biotechnologies’ new brand and website in late 2021, successfully establishing their reputation and image. As of mid 2023, Roswell Biotechnologies is continuing its growth and development under the same brand under new ownership.